https://www.apotex.com/ca/en/about-us/our-leadership/pradeep-sanghvi 1 https://www.apotex.com/ca/fr/about-us/notre-direction/pradeep-sanghvi 1 https://www.apotex.com/ca/en/careers/working-with-us 1 https://www.apotex.com/ca/fr/carrieres/travailler-avec-nous 1 https://www.apotex.com/ca/en/contact-us/customer-service 1 https://www.apotex.com/ca/fr/pour-nous-joindre/customer-service 1 https://www.apotex.com/ca/en/about-us/our-leadership/barry-fishman 1 https://www.apotex.com/ca/fr/about-us/notre-direction/barry-fishman 1 https://www.apotex.com/ca/fr/pour-nous-joindre/international-corporate-development 1 https://www.apotex.com/ca/en/contact-us/international-corporate-development 1 https://www.apotex.com/ca/fr/pour-nous-joindre/dispedia 1 https://www.apotex.com/ca/en/contact-us/dispedia 1 https://www.apotex.com/ca/en/about-us/our-leadership/carina-vassilieva 1 https://www.apotex.com/ca/fr/about-us/notre-direction/carina-vassilieva 1 https://www.apotex.com/ca/en/about-us/our-leadership/kiran-krishnan 1 https://www.apotex.com/ca/fr/about-us/notre-direction/kiran-krishnan 1 https://www.apotex.com/ca/en/careers 1 https://www.apotex.com/ca/fr/carrieres 1 https://www.apotex.com/ca/en/about-us/our-leadership/brian-mcclelland 1 https://www.apotex.com/ca/fr/about-us/notre-direction/brian-mcclelland 1 https://www.apotex.com/ca/en/about-us/our-leadership 1 https://www.apotex.com/ca/fr/about-us/notre-direction 1 https://www.apotex.com/ca/en/contact-us/canadian-sales 1 https://www.apotex.com/ca/fr/pour-nous-joindre/canadian-sales 1 https://www.apotex.com/ca/fr/adverse-reaction-contact-information 1 https://www.apotex.com/ca/en/adverse-reaction-contact-information 1 https://www.apotex.com/ca/en/about-us/our-leadership/martin-ares 1 https://www.apotex.com/ca/fr/about-us/notre-direction/martin-ares 1 https://www.apotex.com/ca/fr/pour-nous-joindre/international-business-development 1 https://www.apotex.com/ca/en/contact-us/international-business-development 1 https://www.apotex.com/ca/en/news/news-release 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse 1 https://www.apotex.com/ca/en/contact-us 1 https://www.apotex.com/ca/fr/pour-nous-joindre 1 https://www.apotex.com/ca/en/about-us/manufacturing-excellence 1 https://www.apotex.com/ca/fr/about-us/excellence-en-matiere-de-fabrication 1 https://www.apotex.com/ca/en/about-us/our-impact 1 https://www.apotex.com/ca/fr/about-us/notre-impact 1 https://www.apotex.com/ca/en/about-us/our-leadership/ariel-alon 1 https://www.apotex.com/ca/fr/about-us/notre-direction/ariel-alon 1 https://www.apotex.com/ca/en/resources/patient-assistance 1 https://www.apotex.com/ca/fr/ressources/ressources-educatives-pour-les-patients 1 https://www.apotex.com/ca/fr/pour-nous-joindre/united-states-customer-service-sales-contacts 1 https://www.apotex.com/ca/en/contact-us/united-states-customer-service-sales-contacts 1 https://www.apotex.com/ca/fr/pour-nous-joindre/media-relations 1 https://www.apotex.com/ca/en/contact-us/media-relations 1 https://www.apotex.com/ca/en/news 1 https://www.apotex.com/ca/fr/nouvelles 1 https://www.apotex.com/ca/fr/juridique/legal-and-copyright-terms 1 https://www.apotex.com/ca/en/legal/legal-and-copyright-terms 1 https://www.apotex.com/ca/en/resources 1 https://www.apotex.com/ca/fr/ressources 1 https://www.apotex.com/ca/fr/pour-nous-joindre/corporate-information 1 https://www.apotex.com/ca/en/contact-us/corporate-information 1 https://www.apotex.com/ca/en/contact-us/webmaster 1 https://www.apotex.com/ca/fr/pour-nous-joindre/webmaster 1 https://www.apotex.com/ca/en/about-us/our-leadership/christine-baeder 1 https://www.apotex.com/ca/fr/about-us/notre-direction/christine-baeder 1 https://www.apotex.com/ca/en/about-us/our-leadership/jeff-watson 1 https://www.apotex.com/ca/fr/about-us/notre-direction/jeff-watson 1 https://www.apotex.com/ca/en/careers/our-winning-culture 1 https://www.apotex.com/ca/fr/carrieres/notre-culture-gagnante 1 https://www.apotex.com/ca/en/contact-us/north-american-business-development 1 https://www.apotex.com/ca/fr/pour-nous-joindre/north-american-business-development 1 https://www.apotex.com/ca/en/portfolio 1 https://www.apotex.com/ca/fr/notre-portefeuille 1 https://www.apotex.com/ca/fr/about-us/excellence-en-matiere-de-fabrication/allergen-information 1 https://www.apotex.com/ca/en/about-us/manufacturing-excellence/allergen-information 1 https://www.apotex.com/ca/fr/juridique/privacy-policy 1 https://www.apotex.com/ca/en/legal/privacy-policy 1 https://www.apotex.com/ca/fr/ressources/professionnels-de-la-sante 1 https://www.apotex.com/ca/en/resources/healthcare-professionals 1 https://www.apotex.com/ca/en/about-us/manufacturing-excellence/our-facilities 1 https://www.apotex.com/ca/fr/about-us/excellence-en-matiere-de-fabrication/nos-installations 1 https://www.apotex.com/ca/en/about-us/our-purpose 1 https://www.apotex.com/ca/fr/about-us/notre-mission 1 https://www.apotex.com/ca/fr/home 1 https://www.apotex.com/ca/en/home 1 https://www.apotex.com/ca/en/about-us/our-leadership/francesco-tallarico 1 https://www.apotex.com/ca/fr/about-us/notre-direction/francesco-tallarico 1 https://www.apotex.com/ca/en/contact-us/compliance-officer 1 https://www.apotex.com/ca/fr/pour-nous-joindre/privacy-officer 1 https://www.apotex.com/ca/en/about-us 1 https://www.apotex.com/ca/fr/about-us 1 https://www.apotex.com/ca/en/news/news-release/2020/02/05/voluntary-recall-of-apo-metformin-er-metformin-hydrochloride-extended-release-tablets-500mg-tablets 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2020/02/05/rappel-volontaire-des-comprimes-de-500-mg-de-apo-metformin-er-comprimes-de-chlorhydrate-de-metformine-a-liberation-prolongee 1 https://www.apotex.com/ca/en/news/news-release/2020/04/21/canada-s-apotex-donates-two-million-dosages-of-hydroxychloroquine-to-the-public-health-agency-of-canada 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2020/04/21/apotex-fait-don-de-deux-millions-de-doses-d-hydroxychloroquine-a-l-agence-de-la-sante-publique-du-canada 1 https://www.apotex.com/ca/en/news/news-release/2020/05/25/toronto-company-launches-hiring-blitz-during-covid-19 1 https://www.apotex.com/ca/en/news/news-release/2020/05/26/canada-s-largest-pharmaceutical-manufacturer-donates-thousands-of-bottles-of-hand-sanitizer-to-hospitals-across-quebec 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2020/05/26/le-plus-grand-fabricant-de-produits-pharmaceutiques-du-canada-fait-don-de-milliers-de-bouteilles-de-desinfectant-pour-les-mains-a-des-hopitaux-du-quebec 1 https://www.apotex.com/ca/en/news/news-release/2020/06/12/voluntary-recall-of-apo-metformin-er-metformin-hydrochloride-extended-release-tablets-500mg-tablets 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2020/06/12/rappel-volontaire-des-comprimes-de-500-mg-de-apo-metformin-er-comprimes-de-chlorhydrate-de-metformine-a-liberation-prolongee 1 https://www.apotex.com/ca/en/news/news-release/2021/04/13/voluntary-recall-of-one-1-lot-of-apo--amitriptyline-amitriptyline-hydrochloride-tablets-usp-10-mg-lot-rf0410 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2021/04/13/rappel-volontaire-d-un-1-lot-de-apo--amitriptyline-comprimes-de-chlorhydrate-d-amitriptyline-usp-10-mg-lot-rf0410 1 https://www.apotex.com/ca/en/news/news-release/2021/04/15/government-of-canada-awards-apotex-inc-a-significant-contract-to-supply-a-safety-net-of-additional-dexamethasone-in-canada 1 https://www.apotex.com/ca/en/news/news-release/2021/04/29/voluntary-recall-of-one-1-lot-of-apo--amitriptyline-amitriptyline-hydrochloride-tablets-usp-10-mg-lot-py1831 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2021/04/29/rappel-volontaire-d-un-1-lot-de-apo--amitriptyline-comprimes-de-chlorhydrate-d-amitriptyline-usp-10-mg-lot-py1831 1 https://www.apotex.com/ca/en/news/news-release/2021/09/01/canadian-made-generic-option-to-treat-multiple-myeloma-now-available 1 https://www.apotex.com/ca/en/news/news-release/2021/09/30/voluntary-nationwide-recall-one-lot-of-mirvala-28-desogestrel-and-ethinyl-estradiol-tablets-usp-0-150-mg-0-030-mg-due-to-possibility-of-one-placebo-pill-in-place-of-an-active-pill 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2021/09/30/rappel-volontaire-a-l-echelle-nationale-un-lot-de-mirvalamc-28-comprimes-de-desogestrel-et-d-ethinylestradiol-usp-a-0-150-mg-0-030-mg-en-raison-de-la-possibilite-qu-un-comprime-actif-ait-ete-remplace-par-un-comprime-de-placebo 1 https://www.apotex.com/ca/en/news/news-release/2022/01/19/voluntary-recall-of-one-1-lot-of-apo--amitriptyline-amitriptyline-hydrochloride-tablets-usp-10-mg-lot-py1832 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2022/01/19/rappel-volontaire-d-un-1-lot-de-apo--amitriptyline-comprimes-de-chlorhydrate-d-amitriptyline-usp-10-mg-lot-py1832 1 https://www.apotex.com/ca/en/news/news-release/2022/04/26/voluntary-recall-of-five-5-lots-of-apo-acyclovir-acyclovir-tablets-apotex-standard-200-mg-and-800-mg 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2022/04/26/rappel-volontaire-de-cinq-5-lots-d-apo-acyclovir-comprimes-d-acyclovir-norme-apotex-a-200-mg-et-800-mg 1 https://www.apotex.com/ca/en/news/news-release/2022/05/17/apotex-launches-affordable-generic-option-to-treat-relapsing-remitting-multiple-sclerosis 1 https://www.apotex.com/ca/en/news/news-release/2021/11/30/canada-wide-contest-recognizes-the-impact-of-pharmacy-professionals-on-patient-care 1 https://www.apotex.com/ca/en/news/news-release/2021/11/09/patient-access-to-affordable-cancer-treatment-increases-with-the-launch-of-new-biosimilar-in-canada 1 https://www.apotex.com/ca/en/news/news-release/2021/09/27/canadian-cancer-patients-have-new-affordable-treatment-option 1 https://www.apotex.com/ca/en/news/news-release/2020/04/17/canada-s-apotex-donates-critical-n95-masks-to-support-frontline-healthcare-workers 1 https://www.apotex.com/ca/en/news/news-release/2020/04/13/canada-s-largest-pharmaceutical-company-produces-hand-sanitizer-to-support-the-fight-against-covid-19 1 https://www.apotex.com/ca/en/news/news-release/2020/03/20/apotex-donates-hydroxychloroquine-for-a-clinical-study-to-prevent-infection-from-covid-19-with-front-line-health-care-workers 1 https://www.apotex.com/ca/en/news/news-release/2022/07/20/first-generic-alternative-to-eliquis-now-available-in-canada 1 https://www.apotex.com/ca/en/news/news-release/2022/07/27/voluntary-recall-of-four-4-lots-of-apo-acyclovir-acyclovir-tablets-apotex-standard-200-mg-and-800-mg 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2022/07/27/rappel-volontaire-de-quatre-4-lots-d-apo-acyclovir-comprimes-d-acyclovir-norme-apotex-a-200-mg-et-800-mg 1 https://www.apotex.com/ca/en/news/news-release/2022/09/28/sk-capital-to-acquire-apotex-a-global-leader-in-affordable-pharmaceuticals 1 https://www.apotex.com/ca/en/news/news-release/2022/12/16/accessa-becomes-the-patient-support-program-manager-for-apotex-inc-apo-deferasirox-and-apo-deferasirox-type-j-products 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2022/12/16/accessa-devient-le-gestionnaire-du-programme-de-soutien-aux-patients-pour-les-produits-apo-deferasirox-mc-et-apo-deferasirox-type-j-mc-d-apotex-inc 1 https://www.apotex.com/ca/en/news/news-release/2023/02/01/voluntary-recall-of-one-1-lot-of-apo-amitriptyline-amitriptyline-hydrochloride-tablets-usp-10-mg-lot-py1904 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2023/02/01/rappel-volontaire-d-un-1-lot-de-apo-amitriptyline-comprimes-de-chlorhydrate-d-amitriptyline-usp-10-mg-lot-py1904 1 https://www.apotex.com/ca/en/news/news-release/2023/04/03/sk-capital-completes-acquisition-of-apotex-a-global-leader-in-affordable-pharmaceuticals 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2023/04/03/sk-capital-finalise-l-acquisition-d-apotex-un-chef-de-file-mondial-dans-le-domaine-des-produits-pharmaceutiques-abordables 1 https://www.apotex.com/ca/en/news/news-release/2023/08/09/voluntary-recall-of-three-3-lots-of-apo-amitriptyline-amitriptyline-hydrochloride-tablets-usp 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2023/08/09/rappel-volontaire-de-trois-3-lots-d-apo-amitriptyline-comprimes-de-chlorhydrate-d-amitriptyline-usp 1 https://www.apotex.com/ca/en/news/news-release/2023/08/09/voluntary-recall-of-seven-7-lots-of-apo-acyclovir-acyclovir-tablets-apotex-standard 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2023/08/09/rappel-volontaire-de-sept-7-lots-d-apo-acyclovir-comprimes-d-acyclovir-norme-apotex 1 https://www.apotex.com/ca/en/news/news-release/2024/02/16/harrow-licenses-canadian-rights-to-apotex-for-five-branded-ophthalmic-pharmaceutical-products 1 https://www.apotex.com/ca/en/news/news-release/2024/04/02/apotex-to-acquire-searchlight-pharma--a-canadian-specialty-branded-pharmaceutical-leader 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2024/04/02/apotex-fera-lacquisition-de-pharmaceutique-searchlight--un-chef-de-file-canadien-des-produits-pharmaceutiques-de-marque-specialisee 1 https://www.apotex.com/ca/en/news/news-release/2024/06/03/apotex-completes-acquisition-of-searchlight-a-leading-canadian-based-specialty-innovative-branded-pharmaceutical-company 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2024/06/03/apotex-conclut-lacquisition-de-searchlight-une-entreprise-pharmaceutique-specialisee-et-novatrice-de-premier-plan-etablie-au-canada 1 https://www.apotex.com/ca/en/news/news-release/2024/07/03/apotex-further-expands-oncology-franchise-through-the-acquisition-of-canadian-rights-to-toripalimab 1 https://www.apotex.com/ca/en/news/news-release/2024/08/07/apotex-expands-ophthalmic-franchise-through-the-acquisition-of-canadian-rights-to-app13007-clobetasol-propionate-ophthalmic-suspension--0.05---a-novel-steroid-for-ophthalmology 1 https://www.apotex.com/ca/en/news/news-release/2024/10/16/voluntary-recall-of-twenty-seven-27-lots-of-apo-amitriptyline-amitriptyline-hydrochloride-tablets-usp 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2024/10/16/rappel-volontaire-de-vingt-sept-27-lots-dapo-amitriptyline-comprimes-de-chlorhydrate-d-amitriptyline-usp 1 https://www.apotex.com/ca/en/news/news-release/2024/12/10/apotex-announces-launch-of-the-apotex-global-health-access-fund-to-promote-health-equity-with--250-000-in-annual-funding-to-the-rexdale-community-health-centre 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2024/12/10/apotex-annonce-le-lancement-du-fonds-dacces-a-la-sante-mondiale-apotex-pour-promouvoir-lequite-en-matiere-de-sante-avec-un-financement-annuel-de-250-000---au-centre-de-sante-communautaire-de-rexdale 1 https://www.apotex.com/ca/en/news/news-release/2025/01/31/voluntary-recall-of-five-5-lots-of-apo-quetiapine-xr-quetiapine-fumarate-extended-release-tablets 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2025/01/31/rappel-volontaire-de-cinq-5-lots-d-apo-quetiapine-xr-comprimes-de-fumarate-de-quetiapine-a-liberation-prolongee 1 https://www.apotex.com/ca/en/news/news-release/2025/02/03/apotex-enters-the-growing-canadian-health-and-wellness-sector-through-the-acquisition-of-canprev--a-leading-canadian-natural-health-company 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2025/02/03/apotex-fait-son-entree-dans-le-secteur-de-la-sante-et-du-bien-etre--un-secteur-en-pleine-croissance-au-canada--grace-a-l-acquisition-de-canprev--une-societe-canadienne-de-premier-plan-dans-le-domaine-de-la-sante-naturelle 1 https://www.apotex.com/ca/en/news/news-release/2025/02/05/apotex--through-its-specialty-pharma-division--searchlight--expands-branded-dermatology-portfolio-through-the-in-licensing-of-the-canadian-rights-to-seysara--sarecycline-and-finjuve--finasteride 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2025/02/05/apotex--par-lintermediaire-de-sa-division-pharmaceutique-specialisee-searchlight--elargit-son-portefeuille-de-produits-dermatologiques-de-marque-grace-a-l-acquisition-sous-licence-des-droits-canadiens-sur-seysaraMD-sarecycline---finjuveMC-finasteride 1 https://www.apotex.com/ca/en/news/news-release/2025/02/05/apotex-acquires-us-rights-to-provigil--modafinil-and-nuvigil--armodafinil 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2025/02/05/apotex-acquiert-les-droits-americains-sur-provigilMD-modafinil-et-nuvigilMD-armodafinil 1 https://www.apotex.com/ca/en/news/news-release/2025/02/13/apotex-announces-grant-to-healthy-mothers--healthy-babies-coalition-of-broward-county-to-promote-maternal-health-with--242-000-in-annual-funding 1 https://www.apotex.com/ca/en/news/news-release/2025/02/24/apotex-licenses-exclusive-canadian-rights-to-qutenza--from-grunenthal 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2025/02/24/apotex-obtient-les-droits-exclusifs-sous-licence-au-canada-pour-qutenza--aupres-de-grunenthal 1 https://www.apotex.com/ca/en/news/news-release/2025/03/27/apotex-announces--100-000-in-annual-funding-to-advance-maternal-and-infant-health-in-mexico 1 https://www.apotex.com/ca/en/news/news-release/2025/05/01/apotex-announces-grant-to-foundation-for-mother-and-child-health-to-promote-maternal-health-with-cad--100-000-in-annual-funding 1 https://www.apotex.com/ca/en/news/news-release/2025/05/20/apotex-publishes-2024-sustainability-report--highlighting-progress-and-achievements-in-environmentally-sustainable-manufacturing--responsible-business-practices--and-social-impact 1 https://www.apotex.com/ca/en/news/news-release/2025/07/02/apotex-receives-health-canada-approval-for-aflivu---a-biosimilar-to-eylea---available-in-pre-filled-syringe-and-vial-formats 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2025/07/02/apotex-a-recu-l-approbation-de-sante-canada-pour-aflivu--un-biosimilaire-a-eylea--disponible-en-seringues-preremplies-et-en-flacons 1 https://www.apotex.com/ca/en/news/news-release/2025/10/07/apotex-strengthens-commitment-to-womens-health-with-exclusive-canadian-rights-to-linzagolix-for-uterine-fibroid-treatment 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2025/10/07/apotex-renforce-son-engagement-envers-la-sante-des-femmes-en-acquerant-les-droits-exclusifs-canadiens-sur-le---linzagolix---pour-le-traitement-des-fibromes-uterins 1 https://www.apotex.com/ca/en/news/news-release/2025/10/08/apotex-supports-launch-of-home-based-cancer-care-with-1-5m-donation 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2025/10/08/apotex-soutient-le-lancement-des-soins-a-domicile-contre-le-cancer-avec-un-don-de-1-5-million-de-dollars 1 https://www.apotex.com/ca/en/news/news-release/2025/10/23/apotex-receives-health-canada-approval-for-loqtorzi-the-first-and-only-immuno-therapy-for-recurrent-unresectable-or-metastatic-nasopharyngeal-cancer 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2025/10/23/apotex-recoit-l-approbation-de-sante-canada-pour-loqtorzi-le-premier-et-seul-traitement-du-cancer-du-nasopharynx-recurrent-non-resecable-ou-metastatique 1 https://www.apotex.com/ca/en/news/news-release/2025/11/17/apotex-donation-helps-oak-valley-health-respond-to-urgent-capacity-needs-amid-rapid-community-growth 1 https://www.apotex.com/ca/en/news/news-release/2026/02/05/apotex-licenses-exclusive-canadian-rights-to-testosterone-replacement-therapy-nebido--from-grunenthal 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/02/05/apotex-detient-les-droits-exclusifs-au-canada-sur-le-traitement-substitutif-de-la-testosterone-nebido-de-grunenthal 1 https://www.apotex.com/ca/en/news/news-release/2026/03/25/apotex-expands-canadian-ophthalmology-portfolio-with-health-canada-s-approval-of-clobivis--(clobetasol-propionate-ophthalmic-suspension--0.05-) 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/03/25/apotex-elargit-son-portefeuille-de-produits-ophtalmologiques-au-canada-grace-a-l-approbation-par-sante-canada-de-clobivismd--suspension-ophtalmique-de-propionate-de-clobetasol--0-05--- 1 https://www.apotex.com/ca/en/news/news-release/2026/03/30/apotex-announces-leadership-changes 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/03/30/apotex-annonce-des-changements-dans-son-leadership 1 https://www.apotex.com/ca/en/news/news-release/2026/04/07/apotex-strengthens-osteoporosis-care-in-canada-with-health-canada-s-approval-of-denoza-a-denosumab-biosimilar 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/04/07/apotex-renforce-les-soins-contre-losteoporose-au-canada-grace-a-lapprobation-par-sante-canada-de-denoza-un-biosimilaire-du-denosumab 1 https://www.apotex.com/ca/en/news/news-release/2026/04/23/apotex-announces-strategic-transaction-with-cumberland-pharmaceuticals-to-integrate-their-u.s.-branded-businesses 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/04/23/apotex-annonce-une-transaction-strategique-avec-cumberland-pharmaceuticals-pour-integrer-leurs-activites-de-marque-aux-etats-unis 1 https://www.apotex.com/ca/en/news/news-release/2026/05/01/apotex-becomes-the-first-canadian-based-global-pharmaceutical-company-to-receive-health-canada-approval-for-a-generic-equivalent-of-ozempic 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/05/01/apotex-devient-la-premiere-entreprise-pharmaceutique-mondiale-basee-au-canada-a-recevoir-lapprobation-de-sante-canada-pour-un-equivalent-generique-dozempic 1 https://www.apotex.com/ca/en/news/news-release/2026/05/14/apotex-launches-apo-semaglutide-injection-a-generic-equivalent-of-ozempic-in-canada 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/05/14/apotex-lance-apo-semaglutide-injection-un-equivalent-generique-de-lozempic-au-canada 1 https://www.apotex.com/ca/en/news/news-release/2026/05/26/apotex-expands-ophthalmic-portfolio-with-health-canada-approval-of-iheezo 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/05/26/apotex-elargit-sa-gamme-de-produits-ophtalmiques-grace-a-lapprobation-de-iheezo-par-sante-canada 1 https://www.apotex.com/ca/en/news/news-release/2026/05/28/apotex-health-corp-files-preliminary-prospectus-for-initial-public-offering 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/05/28/apotex-health-corp-depose-un-prospectus-provisoire-en-vue-dun-premier-appel-public-a-lepargne 1 https://www.apotex.com/ca/en/news/news-release/2026/06/01/apotex-health-corp-launches-its-initial-public-offering 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/06/01/apotex-health-corp-lance-son-premier-appel-public-a-l-epargne 1 https://www.apotex.com/ca/en/news/news-release/2026/06/09/apotex-health-corp-upsizes-its-initial-public-offering 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/06/09/apotex-health-corp-majore-son-premier-appel-public-a-lepargne 1 https://www.apotex.com/ca/en/news/news-release/2026/06/10/apotex-health-corp-files-final-prospectus-and-announces-pricing-of-upsized-initial-public-offering 1 https://www.apotex.com/ca/en/news/news-release/2026/06/16/apotex-health-corp-announces-closing-of-upsized-initial-public-offering-and-exercise-of-over-allotment-option-in-full 1 https://www.apotex.com/ca/en/news/news-release/2026/06/30/apotex-first-to-receive-health-canada-approval-for-sevmia-a-generic-semaglutide-for-chronic-weight-management 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/06/30/apotex-est-la-premiere-entreprise-a-recevoir-une-autorisation-de-sante-canada-pour-sevmia-une-version-generique-du-semaglutide-destine-a-la-prise-en-charge-des-problemes-de-poids-chroniques 1 https://www.apotex.com/ca/en/news/news-release/2026/07/01/apotex-completes-previously-announced-strategic-transaction-with-cumberland-pharmaceuticals 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/07/01/apotex-finalise-la-transaction-strategique-precedemment-annoncee-avec-cumberland-pharmaceuticals 1 https://www.apotex.com/ca/en/news/news-release/2026/07/17/apotex-receives-investment-grade-issuer-rating-from-morningstar-dbrs-and-announces-amended-restated-credit-agreement 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/07/17/apotex-recoit-de-dbrs-morningstar-une-cote-demetteur-de-categorie-investissement-et-annonce-un-accord-de-credit-modifie-et-reformule 1 https://www.apotex.com/ca/en/news/news-release/2026/08/12/apotex-announces-first-quarter-2027-results 1 https://www.apotex.com/ca/fr/nouvelles/communique-de-presse/2026/08/12/apotex-annonce-ses-resultats-du-premier-trimestre-2027 1